Invitrogen Launches Enriched Online Retail Experience for Its Award-Winning Website
LIFE | Quote | Chart | News | PowerRating -- Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE),
today announced significant enhancements to its online store: www.invitrogen.com.
These improvements simplify product selection and ordering, and further
streamline laboratory workflows for users of the site, which is the
top-rated online source for life science products.
The new features are part of a series of improvements designed to create
a significantly enhanced online retail experience for scientists who are
increasingly using the Web to inform their purchase decisions and to buy
the products they need to conduct their experiments. Transactions
processed through this 24/7 online global store offer convenience for
customers ordering reagents and other consumable products, and are
significantly less expensive to process, compared to purchases made
through other channels. Among the enhanced features are:
--
Comprehensive Product Details: Product information has been
expanded to include real-time availability and pricing. Comprehensive
scientific reference information is also now available for all
products, including instructional guides, specifications, and industry
protocols and documentation.
--
Self Service: New self-service features eliminate the need to
phone customer service or sales reps for daily order management. These
capabilities are designed for laboratories and individual end-users to
conveniently manage account details and order history online.
--
Enhanced Online Purchasing: New, best-in-class shopping cart
features have been added to enable management of multiple carts,
provide secured order workflow, and facilitate cart collaboration with
other registered users of Invitrogen.com.
--
Streamlined Oligo Design: Genomic researchers can design oligos
for tubes and plates more efficiently as a result of new, simplified
templates that facilitate easy ordering of multiple sequences at once.
This feature includes online guides that walk users through the entire
ordering process, including contextual help messages and other
assistance.
With more than 1 million visits per month, Invitrogen.com is
Invitrogen's primary channel for customer self service and order
management. The site is organized around 10 application storefronts,
which are designed to support the various ways scientists work, such as cloning,
cell
culture, drug
discovery, and bioproduction.
It has earned multiple awards, including the Life
Science Industry Awards designation as "Most Useful Website" in
2006, 2007 and 2008, and The Scientist's Readers'
Choice Award in 2004. Invitrogen.com brings together leading brands
in scientific research, including GIBCO(R),
Molecular
Probes(R), and Dynal(R),
select Applied
Biosystems reagents and enzymes for PCR and real-time PCR, and a
complete line of Ambion
RNA products.
Bernd Brust, Chief Commercial Officer, Life Technologies
"The Web is an important channel in Life Technologies' marketing and
demand generation efforts. We've created an online environment for
communicating with our customers, who want the flexibility to interact
with us when they want, and at whatever level of frequency they choose.
We will continue to make significant investments in our total eBusiness
strategy, encompassing both Invitrogen.com and Applied Biosystems.com."
Siddhartha C. Kadia, Ph.D., Chief Marketing Officer, Life Technologies
"The new enhancements to Invitrogen.com have been implemented to
maintain its distinction as the life science industry's premier online
retail destination, featuring the broadest selection of differentiated
products from a single source. These changes are driven by feedback from
our customers regarding how we could better serve them by tailoring the
site to the ways scientists want to research and buy products, making it
easier and quicker for them to find exactly what they need to accelerate
their research."
About Invitrogen Products
Invitrogen is a leading provider of platform independent, essential life
science technologies for disease and drug research, bioproduction and
diagnostics. Invitrogen, together with Applied Biosystems -- a global
leader in providing innovative instrument systems to accelerate academic
and clinical research, drug discovery and development, pathogen
detection and forensic DNA analysis -- is part of Life Technologies
Corporation, which markets the life science industry's most
comprehensive portfolio of solutions for molecular and cell biology.
Invitrogen and Applied Biosystems products are used in nearly every
major laboratory in the world.
For more information, please visit: http://www.invitrogen.com
and www.appliedbiosystems.com.
About Life Technologies
Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology
tools company dedicated to improving the human condition. Our systems,
consumables and services enable researchers to accelerate scientific
exploration, driving to discoveries and developments that make life even
better. Life Technologies customers do their work across the biological
spectrum, working to advance personalized medicine, regenerative
science, molecular diagnostics, agricultural and environmental research,
and 21st century forensics. Life Technologies had sales of more than $3
billion in 2008, employs approximately 9,500 people, has a presence in
more than 100 countries, and possesses a rapidly growing intellectual
property estate of approximately 3,600 patents and exclusive licenses.
Life Technologies was created by the combination of Invitrogen
Corporation and Applied Biosystems Inc. For more information on how we
are making a difference please visit our website: www.lifetechnologies.com.
Safe Harbor Statement
This press release includes forward-looking statements about our
anticipated results that involve risks and uncertainties. Some of the
information contained in this press release, including, but not limited
to, statements as to industry trends and Life Technologies' plans,
objectives, expectations and strategy for its business, contains
forward-looking statements that are subject to risks and uncertainties
that could cause actual results or events to differ materially from
those expressed or implied by such forward-looking statements. Any
statements that are not statements of historical fact are
forward-looking statements. When used, the words "believe," "plan,"
"intend," "anticipate," "target," "estimate," "expect" and the like,
and/or future tense or conditional constructions ("will," "may,"
"could," "should," etc.), or similar expressions, identify certain of
these forward-looking statements. Important factors which could cause
actual results to differ materially from those in the forward-looking
statements are detailed in filings made by Life Technologies with the
Securities and Exchange Commission. Life Technologies undertakes no
obligation to update or revise any such forward-looking statements to
reflect subsequent events or circumstances.
Copyright 2009. Life Technologies Corporation. All rights reserved.
Invitrogen is a trademark of Life Technologies in the US and/or certain
other countries. GIBCO, Molecular Probes, and Dynal are registered
trademarks of Invitrogen and Life Technologies.
SOURCE: Life Technologies Corporation
Life Technologies
Renaldo Juanso, 650-638-5354 (Media)
Public Relations
renaldo.juanso@lifetech.com
Amanda Clardy, 760-603-7200 (Investors)
Corporate and Financial Communications
amanda.clardy@lifetech.com
For full details on Life Technologies Corporation (LIFE) LIFE. Life Technologies Corporation (LIFE) has Short Term PowerRatings at TradingMarkets. Details on Life Technologies Corporation (LIFE) Short Term PowerRatings is available at This Link.
- Telegraph Hill Partners sells AcroMetrix to Life Technologies - 02/02/10
- Life Technologies acquires AcroMetrix - 02/02/10
- Danaher acquires remaining 50% stake in AB SCIEX from Life Technologies - 02/02/10
- Life Technologies Responds to Challenge of Detecting Vesivirus 2117 Contamination in Mammalian Cell Culture Manufacturing - 02/02/10
- Life Technologies Posts 4Q and Fiscal Year 2009 Results - 02/02/10
- More News >>


